Wayland Releases Portfolio of Brands & Receives Sales License from Health Canada for Expansion Site

Burlington, Ontario, CANADA

TORONTO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company“) is excited to announce the release of its portfolio of brands that cater to different ages, genders, and occasions. The Company’s extensive research created a portfolio of brands, each designed to address segments of the cannabis market both present and future.  Strategically using each of these brands, Wayland gave itself the ability to be present and relevant to consumers.

“The advent of recreational cannabis legalization in Canada is truly a watershed moment for Canadians. As we lead the world by example on another modern and controversial issue, we are thrilled to be at the forefront to welcome this new age. As a company invested in the long-term growth of the legal cannabis industry, first in providing state-of-the-art, highest-quality medicinals and now, a breadth of recreational products formulated with the same pharmaceutical standards, we know this is just the first step towards educating and demonstrating to the naysayers that legalization is the right path.

"The responsibility now lies with us, the companies behind the products, to show through professionalism and dedication to the highest integrity and operating standards that the benefits far outweigh the risks and that slow and steady wins the race. Working closely with government and our peers to ensure education and safety remain top of mind has been the Company’s operating edict since its humble beginnings on a farm in Norfolk, ON. We have now received the sales license from Health Canada for our expansion in Norfolk and will be able to ship product grown in our state-of-the-art facility,” said Ben Ward, CEO Wayland Group.

Rather than taking a one-size-fits-all approach, Wayland has taken a purposeful and consumer-centric approach to each of its brands and offerings, which was validated with local consumer research. Brands within the portfolio will represent the quality and consistency that Wayland Group is globally recognized for, in addition to satisfying consumer needs.

Fun and approachable.  Kiwi will be the brand people will look to make “all things cannabis” make sense. Designed for light users who are new to the category and looking to better understand cannabis.

High Tide is Wayland’s collection of high-THC cannabis strains designed for experienced medium to heavy users.  

Northern Harvest has something for any cannabis consumer that appreciates authentic, local quality. Designed for light / medium users who enjoy Cannabis.

Lost at seed is a meticulously curated collection of the finest and most rare cannabis genetics. Designed for medium to heavy users who are looking for highly desirable and impossible to find strains.

Solara C will be designed exclusively to produce only the highest quality CBD products. Solara C will strive to educate and give consumers the ability to experience a natural, non- pharmaceutical alternative.

This partner brand will be for experienced cannabis users who are knowledgeable about strains, potencies and profiles.  It will offer a wide selection of premium award-winning strains that users won’t be able to find anywhere else.

Kiwi, Northern Harvest, and High Tide will be available in select markets on October 17th, 2018.

Fast forward to today and our state-of-the-art, heavily automated, food-grade production facilities, investments in leading edge absorption technologies, products focused on the needs of every consumer, a deeply experienced team who have done this before in other legalized markets, and we believe Wayland is poised to deliver on our promise to improve lives through cannabis every day.

Today, Canada takes a leadership position among its global peers, many of which we are working with as they follow down the cannabis legalization path. As a country, we will lead by example. And while there is a lot of noise in the industry as we enter into this era, as is often the case, the future is brightest for those who focus on the work at hand. Success will lie with those who quietly build companies dedicated to customer experiences focused on quality, value and a commitment to getting it right.

Welcome to your future, Canada. We’re excited to be a part of it. 

  • Ben Ward, CEO, Wayland Group

Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.

About Wayland Group

Wayland is a vertically integrated producer and distributor of marijuana for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal license from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada and will continue to pursue new opportunities in Europe.

Forward Looking Statements

This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

For more information about Wayland, please visit our website at www.waylandgroup.com

Investor Relations
Graham Farrell
VP, Communications

Media Inquiries: media@waylandgroup.com

Corporate Headquarters (Canada)
Wayland Group (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3

European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland